Suchergebnisse - "Peyrin-Biroulet, Laurent"

PubPharm (72)

1

Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials

enthalten in: BMC gastroenterology | 2024

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +14

2

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis : QUASAR Phase 2b Induction Study

enthalten in: Gastroenterology | 2023

von Peyrin-Biroulet, L. | Allegretti, J. | Rubin, D. | +115

3

Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes

enthalten in: Journal of Crohn's & colitis | 2023

von Magro, F. | Pai, R. | Kobayashi, T. | +8

4

An update on the safety of long-term vedolizumab use in inflammatory bowel disease

enthalten in: Expert opinion on drug safety | 2023

von Honap, S. | Netter, P. | Danese, S. | +1

5

Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease : Results up to Week 104 of the STARDUST trial

enthalten in: United European gastroenterology journal | 2023

von Panés, J. | Vermeire, S. | D'Haens, G. | +11

6

A critical review of ustekinumab for the treatment of active ulcerative colitis in adults

enthalten in: Expert review of gastroenterology & hepatology | 2023

von Vieujean, S. | Louis, E. | Danese, S. | +1

7

Vedolizumab for the Treatment of Chronic Pouchitis

enthalten in: The New England journal of medicine | 2023

von Travis, S. | Silverberg, M. | Danese, S. | +45

8

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease : a systematic review and meta-analysis

enthalten in: BMC gastroenterology | 2022

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +13

9

Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn's Disease : ENTERPRISE Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Schwartz, D. | Peyrin-Biroulet, L. | Lasch, K. | +2

10

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY) : a phase 3, randomised, controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Peyrin-Biroulet, L. | Hart, A. | Bossuyt, P. | +114

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):2-4. - PMID 34798035

1
2
3
4
5
6
7
8
Nächster »
[8]